T0	Participants 88 129	patients with inflammatory bowel disease.
T1	Participants 368 389	Fifty-six outpatients
T2	Participants 941 981	Thirty-nine subjects completed the study
T3	Participants 1365 1394	CONCLUSIONS Findings indicate